Histogen Announces Board Approval Of Complete Liquidation And Dissolution, Including Distribution Of Remaining Cash To Stockholders Following Operational Winddown; Co. Has Discontinued All Clinical Development Programs And Reduced Workforce
Benzinga Newsdesk - Sep 18, 2023, 4:06PM